ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 1024

$682K Total Retail Price of All Prescriptions

Rank: 134 out of 1024

375 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

14% of this provider’s 375 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 633 608 53 1 3
TRAZODONE HCL 469 449 62 2 22
FUROSEMIDE 449 434 68 3 6
WARFARIN SODIUM 447 442* 20 4 8
LEVOTHYROXINE SODIUM 374 359 58 5 2
METOPROLOL TARTRATE 285 285 48 6 7
ESCITALOPRAM OXALATE 281 276* 33 7 14
DONEPEZIL HCL 271 258 36 8 25
SERTRALINE HCL 251 251 20 9 23
CYMBALTA 246 246 13 10 35
LORAZEPAM 245 240* 51 B 11 26
METOPROLOL SUCCINATE 226 221* 44 12 12
ATORVASTATIN CALCIUM 215 189 53 13 1
OMEPRAZOLE 199 168 39 14 9
NAMENDA 198 198 15 15 27
METFORMIN HCL 186 165 27 16 10
DIOVAN 184 184 16 17 21
SIMVASTATIN 184 168 39 17 5
HYDROCODONE-ACETAMINOPHEN 178 173* 41 S3 19 32
POTASSIUM CHLORIDE 153 148* 21 20 30
PREDNISONE 153 148* 34 20 38
LISINOPRIL 146 141* 33 22 4
CELEBREX 142 137* 22 23 87
VERAPAMIL ER 137 132* 19 24 134
CLOPIDOGREL 129 124* 23 25 28
LYRICA 126 121* 12 26 100
TAMSULOSIN HCL 123 123 24 27 24
FENTANYL 120 115* 15 S2 28 99
PANTOPRAZOLE SODIUM 118 113* 25 29 29
ALLOPURINOL 115 110* 17 30 34
MIRTAZAPINE 112 107* 17 31 31
ATENOLOL 110 110 19 32 13
DIGOX 109 109 16 33 81
PAROXETINE HCL 106 106 11 34 72
CITALOPRAM HBR 105 105 15 35 37
GENERLAC 104 104 23 36 245
HYDROCHLOROTHIAZIDE 88 88 22 37 11
OLANZAPINE 83 <11 <11 A 38 73
OXYCODONE HCL 80 75* 17 S2 39 55
TRAMADOL HCL 80 75* 28 39 36
QUETIAPINE FUMARATE 79 <11 <11 A 41 44
NOVOLOG MIX 70-30 FLEXPEN 77 <11 <11 42 283
POLYETHYLENE GLYCOL 3350 77 77 20 42 97
ZOLPIDEM TARTRATE 75 75 17 44 19
LIDODERM 73 68* 22 45 69
NITROFURANTOIN* 71 <11 <11 46 189
AMILORIDE-HYDROCHLOROTHIAZIDE 71 71 18 46 257
FINASTERIDE 70 <11 <11 48 76
RISPERIDONE 68 <11 <11 A 49 48
RANITIDINE HCL 67 67 17 50 68
TOLTERODINE TARTRATE 60 <11 <11 51 374
ISOSORBIDE MONONITRATE ER 59 54* 13 52 63
NIFEDIPINE ER 57 <11 <11 53 152
NOVOFINE AUTOCOVER 56 56 13 54 303
LOSARTAN POTASSIUM 56 <11 <11 54 16
CARVEDILOL 56 <11 <11 54 40
NOVOLOG FLEXPEN 54 <11 <11 57 144
GLIPIZIDE 54 <11 <11 57 66
LACTULOSE 52 47* 20 59 105
DIVALPROEX SODIUM 51 <11 <11 60 59
OXYCONTIN 51 <11 <11 S2 60 102
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.